110 related articles for article (PubMed ID: 7944313)
1. Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice.
Hostetler KY; Korba BE; Sridhar CN; Gardner MF
Antiviral Res; 1994 May; 24(1):59-67. PubMed ID: 7944313
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice.
Hostetler KY; Richman DD; Sridhar CN; Felgner PL; Felgner J; Ricci J; Gardner MF; Selleseth DW; Ellis MN
Antimicrob Agents Chemother; 1994 Dec; 38(12):2792-7. PubMed ID: 7695264
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
Biochem Pharmacol; 1994 Jan; 47(2):171-4. PubMed ID: 8304960
[TBL] [Abstract][Full Text] [Related]
6. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2',3'-dideoxycytidine.
Makabi-Panzu B; Lessard C; Perron S; Désormeaux A; Tremblay M; Poulin L; Beauchamp D; Bergeron MG
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1463-70. PubMed ID: 7888201
[TBL] [Abstract][Full Text] [Related]
8. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
[TBL] [Abstract][Full Text] [Related]
9. Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP).
Zahm FE; d'Urso N; Bonino F; Ponzetto A
Liver; 1996 Apr; 16(2):88-93. PubMed ID: 8740840
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol.
Shakiba S; Freeman WR; Flores-Aguilar M; Munguia D; Tatebayashi M; Besen G; Amani R; Wiley CA; Vuong C; Aldern KA
Antimicrob Agents Chemother; 1995 Jun; 39(6):1383-5. PubMed ID: 7574537
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-human immunodeficiency virus and anti-hepatitis B virus activities and pharmacokinetic properties of heterodinucleoside phosphates containing AZT or ddC.
Peghini PA; Zahner R; Kuster H; Schott H; Schwendener RA
Antivir Chem Chemother; 1998 Mar; 9(2):117-26. PubMed ID: 9875383
[TBL] [Abstract][Full Text] [Related]
12. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
Korba BA; Xie H; Wright KN; Hornbuckle WE; Gerin JL; Tennant BC; Hostetler KY
Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
[TBL] [Abstract][Full Text] [Related]
13. Uptake and binding of liposomal 2',3'-dideoxycytidine by RAW 264.7 cells: a three-step process.
Makabi-Panzu B; Lessard C; Beauchamp D; Désormeaux A; Poulin L; Tremblay M; Bergeron MG
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):227-35. PubMed ID: 7859133
[TBL] [Abstract][Full Text] [Related]
14. Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.
de Vrueh RL; Rump ET; van De Bilt E; van Veghel R; Balzarini J; Biessen EA; van Berkel TJ; Bijsterbosch MK
Antimicrob Agents Chemother; 2000 Mar; 44(3):477-83. PubMed ID: 10681306
[TBL] [Abstract][Full Text] [Related]
15. Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro.
Schinazi RF; Gosselin G; Faraj A; Korba BE; Liotta DC; Chu CK; Mathé C; Imbach JL; Sommadossi JP
Antimicrob Agents Chemother; 1994 Sep; 38(9):2172-4. PubMed ID: 7811039
[TBL] [Abstract][Full Text] [Related]
16. Highly water-soluble lipophilic prodrugs of the anti-HIV nucleoside analogue 2',3'-dideoxycytidine and its 3'-fluoro derivative.
Kerr SG; Kalman TI
J Med Chem; 1992 May; 35(11):1996-2001. PubMed ID: 1317921
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
Szebeni J; Wahl SM; Betageri GV; Wahl LM; Gartner S; Popovic M; Parker RJ; Black CD; Weinstein JN
AIDS Res Hum Retroviruses; 1990 May; 6(5):691-702. PubMed ID: 2163269
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
Hillaireau H; Dereuddre-Bosquet N; Skanji R; Bekkara-Aounallah F; Caron J; Lepêtre S; Argote S; Bauduin L; Yousfi R; Rogez-Kreuz C; Desmaële D; Rousseau B; Gref R; Andrieux K; Clayette P; Couvreur P
Biomaterials; 2013 Jul; 34(20):4831-8. PubMed ID: 23562054
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacokinetics of a dihydropyridine chemical delivery system for the antiimmunodeficiency virus agent dideoxycytidine.
Torrence PF; Kinjo J; Khamnei S; Greig NH
J Med Chem; 1993 Mar; 36(5):529-37. PubMed ID: 8388473
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys.
Qian MX; Swagler AR; Mehta M; Vishwanathan CT; Gallo JM
Pharm Res; 1992 Feb; 9(2):224-7. PubMed ID: 1313173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
